MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Myoclonus Dystonia: A report of two rare mutations

A. Mahajan, C. Sidiropoulos (Detroit, MI, USA)

Meeting: 2016 International Congress

Abstract Number: 581

Keywords: Dystonia: Genetics, Myoclonus: Genetics

Session Information

Date: Tuesday, June 21, 2016

Session Title: Genetics (NON-PD)

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To present the results of genetic analysis of three patients who presented to our clinic with Myoclonus Dystonia.

Background: Myoclonus Dystonia (MD) is a rare autosomal dominant movement disorder characterized by myoclonic jerks and dystonia, often first seen in patients in their childhood and early adolescence. Most reported mutations are located in the ε-sarcoglycan (SGCE) gene in chromosome 7. Allele specific methylation is primarily responsible for paternal imprinting. A number of mutations of the SGCE gene have been reported in literature. We present two siblings with genetically confirmed MD and a 709C>T mutation and another patient with a c.463+5del in the SGCE gene.

Methods: Samples were collected from 3 patients who presented to the Movement disorders clinic at Henry Ford West Bloomfield Hospital, Michigan with prominent myoclonus. Analysis was performed by PCR amplification of highly purified genomic DNA, followed by automated bi-directional DNA sequencing of the coding region (12 exons, 1386 bp) of the SGCE gene. In exons where one of the strands was not informative for confirmation, uni-directional sequencing with alternative dye chemistry was used for confirmation. Further, a minimum of 20 bases of intronic DNA surrounding each exon were also sequenced.

Results: Mutation 1: Analysis of two patients’ SGCE gene identified a C>T transition at nucleotide 709 and codon 237. The amino acid change identified was arginine > OPA (Stop codon). Mutation 2: Analysis of the patient’s SGCE gene identified a 1 bp c.463+5del.

Conclusions: The first mutation has been reported in the literature and has been associated with the development or predisposition to developing myoclonus dystonia. However, to the best of our knowledge, this is the first one to be reported in North America. The second mutation has never been reported before. Patients who present with pure myoclonus to Movement Disorders Centers should be offered genetic screening for SGCE mutations.

To cite this abstract in AMA style:

A. Mahajan, C. Sidiropoulos. Myoclonus Dystonia: A report of two rare mutations [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/myoclonus-dystonia-a-report-of-two-rare-mutations/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/myoclonus-dystonia-a-report-of-two-rare-mutations/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley